The Latest From CureMatch
Santa Monica-based Quantgene Inc., which is developing a genetic testing technology that can detect cancer through a blood sample, has formed a partnership with San Diego-based cancer therapy guidance company CureMatch Inc. to improve treatments for cancer. The partnership announced March 24 will allow both companies to use their artificial intelligence technologies to provide more […]
Today, Dr. Razelle Kurzrock, CureMatch Co-Founder and Chief Medical Advisor, was recognized as Woman in Tech and a Woman of Influence by the San Diego Business Journal. Board-certified medical oncologist, practicing physician, researcher, and business leader, Dr. Kurzrock has led the evolution of the CureMatch Decision Support System that supports the doctor with therapeutic options […]
SANTA MONICA, Calif., March 24th, 2021 – Quantgene, Inc. and CureMatch, Inc. have announced a strategic partnership to combine genomic, cloud and AI technologies and improve precision treatments and long-term outcomes for patients diagnosed with cancer. Quantgene Liquid uses blood samples of cancer patients to help provide a systemic understanding of the mutational profiles of […]
Leader brings two decades of industry experience in precision medicine, pharmaceutical and translational science to focus on personalized cancer treatments SAN DIEGO, CALIFORNIA, UNITED STATES, December 15, 2020 /EINPresswire.com/ — CureMatch, Inc., a leader in precision medicine digital solutions, has expanded its leadership team naming Ally Perlina, Ph.D., as chief science officer (CSO). In this […]
Only a minority of clinical trials evaluating immunotherapeutic agents in 2019 used a biomarker to select patients for enrollment, a study found. The findings were reported at the virtual Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting & Preconference Programs (SITC 2020). Clinical trials evaluated were listed on ClinicalTrials.gov between January 1, 2019, and […]